Citation Tools

Download PDFPDF
Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial

Download to a citation manager

Cite this article as:
Mirza M, Dørum A, Benigno B, et al
Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial